Home Newsfeeds Wolfe Research Downgrades Northrop Grumman to Peer Perform

Wolfe Research Downgrades Northrop Grumman to Peer Perform

Wolfe Research analyst Myles Walton downgrades Northrop Grumman (NYSE:NOC) from Outperform to Peer Perform.

byBenzinga Newsdesk

January 27, 2023

1 minute read

Wolfe Research analyst Myles Walton downgrades Northrop Grumman (NYSE:NOC) from Outperform to Peer Perform.

Raymond James Maintains Market Outperform on American Tower, Raises Price Target to $233

By Benzinga Newsdesk

November 23, 9:31 AM

Raymond James analyst Ric Prentiss maintains American Tower (NYSE:AMT) with a Market Outperform and raises the price target from $219 to $233.

AMT

Facebook Parent’s New VR Headset Out This Week: All We Know About Meta Quest Pro

By Adrian Zmudzinski

October 10, 12:09 AM

Meta Inc. (NASDAQ: FB) is expected to unveil its next headset — the Quest Pro — during the Meta Connect 2022 conference on Oct. 11.

MSFT

Savara To Present New Data On Autoimmune Pulmonary Alveolar Proteinosis At The American Thoracic Society International Conference 2024

By Benzinga Newsdesk

April 8, 8:28 AM

Savara's Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAPCompany to Host Industry Theater on Pulmonary Alveolar Proteinosis (PAP) with Two World-Renowned ExpertsSavara Inc.

SVRA

Analyst Ratings

Analyst Ratings for TechTarget

By Benzinga Insights

December 20, 12:00 PM

TechTarget (NASDAQ:TTGT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

TTGT

Wolfe Research Downgrades Northrop Grumman to Peer Perform

Related Posts

Raymond James Maintains Market Outperform on American Tower, Raises Price Target to $233

Facebook Parent’s New VR Headset Out This Week: All We Know About Meta Quest Pro

Savara To Present New Data On Autoimmune Pulmonary Alveolar Proteinosis At The American Thoracic Society International Conference 2024

Analyst Ratings for TechTarget